1. Home
  2. VALN vs RLAY Comparison

VALN vs RLAY Comparison

Compare VALN & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VALN
  • RLAY
  • Stock Information
  • Founded
  • VALN 2012
  • RLAY 2015
  • Country
  • VALN France
  • RLAY United States
  • Employees
  • VALN N/A
  • RLAY N/A
  • Industry
  • VALN Biotechnology: Biological Products (No Diagnostic Substances)
  • RLAY Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • VALN Health Care
  • RLAY Health Care
  • Exchange
  • VALN Nasdaq
  • RLAY Nasdaq
  • Market Cap
  • VALN 510.7M
  • RLAY 490.3M
  • IPO Year
  • VALN 2021
  • RLAY 2020
  • Fundamental
  • Price
  • VALN $6.28
  • RLAY $2.99
  • Analyst Decision
  • VALN Strong Buy
  • RLAY Strong Buy
  • Analyst Count
  • VALN 3
  • RLAY 11
  • Target Price
  • VALN $15.33
  • RLAY $18.40
  • AVG Volume (30 Days)
  • VALN 83.3K
  • RLAY 2.2M
  • Earning Date
  • VALN 05-07-2025
  • RLAY 05-05-2025
  • Dividend Yield
  • VALN N/A
  • RLAY N/A
  • EPS Growth
  • VALN N/A
  • RLAY N/A
  • EPS
  • VALN N/A
  • RLAY N/A
  • Revenue
  • VALN $201,099,222.00
  • RLAY $7,679,000.00
  • Revenue This Year
  • VALN $18.74
  • RLAY N/A
  • Revenue Next Year
  • VALN $29.26
  • RLAY $169.23
  • P/E Ratio
  • VALN N/A
  • RLAY N/A
  • Revenue Growth
  • VALN 21.64
  • RLAY N/A
  • 52 Week Low
  • VALN $3.62
  • RLAY $1.78
  • 52 Week High
  • VALN $9.50
  • RLAY $10.72
  • Technical
  • Relative Strength Index (RSI)
  • VALN 47.26
  • RLAY 50.08
  • Support Level
  • VALN $6.18
  • RLAY $2.75
  • Resistance Level
  • VALN $6.54
  • RLAY $3.10
  • Average True Range (ATR)
  • VALN 0.18
  • RLAY 0.20
  • MACD
  • VALN 0.02
  • RLAY 0.01
  • Stochastic Oscillator
  • VALN 45.65
  • RLAY 58.16

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

About RLAY Relay Therapeutics Inc.

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).

Share on Social Networks: